New immune cell attack tested for tough prostate cancer
NCT ID NCT07298239
Summary
This early-stage study is testing a new type of immunotherapy for men with advanced prostate cancer that has stopped responding to standard hormone treatments. Doctors are using specially engineered immune cells, called CAR-NK cells, designed to find and kill prostate cancer cells. The main goals are to see if this treatment is safe and to look for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, 不限, 100000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.